RecruitingNCT05080712

Progression of Atrial Fibrillation in the Young

Sponsor

Karolinska Institutet

Enrollment

100 participants

Start Date

Sep 25, 2021

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation

Summary

The purpose of this study is to investigate the presence and magnitude of structural changes of the heart and their long-term development in young patients with atrial Fibrillation (AF), studied by echocardiographic measurements and plasma biomarkers and their association to AF burden, studied using long-term ECG

Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is following younger adults who have been newly diagnosed with atrial fibrillation (an irregular heart rhythm) to understand how it progresses and what factors influence its development over time. **You may be eligible if...** - You have been diagnosed with atrial fibrillation - Your diagnosis was made within the past year **You may NOT be eligible if...** - Your atrial fibrillation has been present for more than one year - Your atrial fibrillation was triggered by a specific event such as a heart attack or infection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.